ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 163 filers reported holding ACHILLION PHARMACEUTICALS IN in Q3 2016. The put-call ratio across all filers is 0.46 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $112,000 | +69.7% | 18,619 | +1.1% | 0.00% | – |
| Q3 2019 | $66,000 | +61.0% | 18,413 | +20.6% | 0.00% | – |
| Q2 2019 | $41,000 | -33.9% | 15,266 | -27.4% | 0.00% | – |
| Q1 2019 | $62,000 | +121.4% | 21,014 | +21.4% | 0.00% | – |
| Q4 2018 | $28,000 | -68.9% | 17,314 | -29.3% | 0.00% | – |
| Q3 2018 | $90,000 | +11.1% | 24,473 | -14.7% | 0.00% | – |
| Q2 2018 | $81,000 | -34.1% | 28,697 | -13.6% | 0.00% | – |
| Q1 2018 | $123,000 | -22.6% | 33,200 | -39.9% | 0.00% | – |
| Q4 2017 | $159,000 | -50.8% | 55,229 | -23.2% | 0.00% | – |
| Q3 2017 | $323,000 | -47.6% | 71,926 | -46.4% | 0.00% | -100.0% |
| Q2 2017 | $616,000 | +41.6% | 134,156 | +29.9% | 0.00% | 0.0% |
| Q1 2017 | $435,000 | +314.3% | 103,263 | +304.7% | 0.00% | – |
| Q4 2016 | $105,000 | -60.4% | 25,515 | -22.1% | 0.00% | – |
| Q3 2016 | $265,000 | +3.5% | 32,754 | -0.1% | 0.00% | – |
| Q2 2016 | $256,000 | +4.1% | 32,787 | +2.9% | 0.00% | – |
| Q1 2016 | $246,000 | -51.6% | 31,850 | -32.3% | 0.00% | -100.0% |
| Q4 2015 | $508,000 | +68.8% | 47,052 | +8.1% | 0.00% | 0.0% |
| Q3 2015 | $301,000 | -50.5% | 43,517 | -36.6% | 0.00% | 0.0% |
| Q2 2015 | $608,000 | +36.0% | 68,647 | +51.5% | 0.00% | 0.0% |
| Q1 2015 | $447,000 | -20.3% | 45,304 | -1.1% | 0.00% | 0.0% |
| Q4 2014 | $561,000 | -9.2% | 45,828 | -26.0% | 0.00% | 0.0% |
| Q3 2014 | $618,000 | +50.7% | 61,909 | +14.4% | 0.00% | 0.0% |
| Q2 2014 | $410,000 | +978.9% | 54,118 | +365.7% | 0.00% | – |
| Q1 2014 | $38,000 | +2.7% | 11,621 | +4.4% | 0.00% | – |
| Q4 2013 | $37,000 | -76.4% | 11,126 | -42.1% | 0.00% | – |
| Q2 2013 | $157,000 | – | 19,212 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 12,033,220 | $92,896,000 | 11.87% |
| RTW INVESTMENTS, LP | 2,558,859 | $19,754,000 | 7.17% |
| TURNER INVESTMENTS LLC | 859,560 | $6,636,000 | 1.80% |
| DAFNA Capital Management LLC | 236,500 | $1,826,000 | 1.58% |
| Ghost Tree Capital, LLC | 250,000 | $1,930,000 | 1.09% |
| Orbimed Advisors | 11,519,700 | $88,932,000 | 0.94% |
| Rock Springs Capital Management LP | 1,220,000 | $9,418,000 | 0.79% |
| Opus Point Partners Management, LLC | 99,000 | $764,000 | 0.59% |
| Bellevue Group AG | 420,000 | $3,242,000 | 0.59% |
| Cormorant Asset Management, LP | 500,000 | $3,860,000 | 0.58% |